Form 4 for GILD Gilead Sciences
Accepted 2025-07-29 00:00:00 ET · period of report 2025-07-28 · accession 0001127602-25-019732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-07-29 | 2025-07-28 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $113.94 | -10.0K | 614.1K | -2% | -$1.14M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-28 | S | D | 8,345 | $114.09 | 605,725 | D | — | — | (F3) Sale prices reported for the transactions reported here range from $113.71 to $114.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 2 | Common | Common Stock | 2025-07-28 | S | D | 1,655 | $113.17 | 614,070 | D | — | — | (F2) Sale prices reported for the transactions reported here range from $112.71 to $113.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |